Accès à distance ? S'identifier sur le proxy UCLouvain
Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection.
Primary tabs
- Open access
- 3.90 M
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès libre |
Publication date | 2019 |
Language | Anglais |
Journal information | "Journal of controlled release" - Vol. 309, p. 72-81 (2019) |
Peer reviewed | yes |
Publisher | Elsevier Science Publishers ((Netherlands) Amsterdam) |
issn | 0168-3659 |
e-issn | 1873-4995 |
Publication status | Publié |
Affiliations |
UCL
- SSS/LDRI/MCPB - Analyse clinique par spectrométrie de masse de métabolites et de composés d'intérêts pharmaceutique et biologique UCL - SSS/LDRI - Louvain Drug Research Institute UCL - SST/IMCN/BSMA - Bio and soft matter |
Keywords | Combination therapy ; Glioblastoma ; Hydrogel ; Local delivery ; Nanomedicine ; Nanoparticles |
Links |
Bibliographic reference | Zhao, Mengnan ; Bozzato, Elia ; Joudiou, Nicolas ; Ghiassinejad, Sina ; Danhier, Fabienne ; et. al. Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection.. In: Journal of controlled release, Vol. 309, p. 72-81 (2019) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/218317 |